Long-term opioid use fails to alleviate chronic back pain, Northwestern University study suggests
Researchers identified distinct brain activity patterns and molecular markers that may guide future treatments for pain management and opioid tapering.
A recent investigation conducted by Northwestern University suggests that extended use of prescription opioids does not appear to decrease pain levels or enhance physical functioning for individuals suffering from chronic back pain. Published in the journal Brain on October 1, the study compared the experiences and neurological profiles of long-term opioid users against a control group of similar patients who do not use the medication.
The research team analyzed two distinct groups of participants, both of whom suffered from chronic back pain. The first group consisted of 70 individuals who had been using prescription opioids daily for an average of 7.8 years. The second group included 70 closely matched patients who were not using opioids to manage their condition. According to the study, both groups reported nearly the same level of pain, averaging approximately 5.4 on a 10-point scale.
While pain levels remained similar, the researchers noted that the group using opioids experienced slightly lower scores regarding their mental health and physical functionality. However, A. Vania Apkarian, the director of the Center for Translational Pain Research at Northwestern University Feinberg School of Medicine and a senior author of the study, noted that the psychological and neurological properties of the opioid-using participants remained largely intact. Apkarian suggested that these findings may address contemporary concerns regarding whether opioid ingestion causes drastic changes to brain structure, noting that the participants in this study were all taking low or moderate doses under the supervision of medical professionals.
To investigate how long-term medication affects the brain, the scientists utilized functional MRI technology to monitor changes in blood flow, which serves as a measure of brain activity. The study found no significant evidence that years of opioid use had altered the physical anatomy of the brain. However, the researchers observed significant differences in spontaneous brain activity and the way different brain regions communicate.
Advertisement
These functional differences were particularly prominent in the prefrontal cortex, a region associated with decision-making, and the mesocorticolimbic network, which is involved in motivation and reward systems. To analyze these patterns, the research team developed a new computational method that integrated MRI data with established brain maps of neurotransmitter receptors. This approach allowed them to identify specific molecular signatures related to long-term opioid use and various aspects of chronic pain.
The study identified that these molecular markers involved activity within opioid and serotonin receptors. Apkarian indicated that identifying these specific brain states is a significant development, as it provides potential indicators for determining which pharmaceutical treatments might be effective and which should be avoided in the future.
The identification of these molecular markers may have implications for both pain management and the process of reducing opioid dependency. The researchers also observed a subset of 21 patients who had finished a four-week rehabilitation program for pain. Within this small group, eight individuals successfully decreased their opioid consumption by more than 30%. The brain activity of these patients showed changes linked to the previously identified serotonin and opioid receptors, which the researchers believe supports the idea that these markers could help guide future clinical interventions.
Based on the discovery of the serotonin molecular pathway, the Northwestern scientists intend to investigate whether certain antidepressants can be utilized to treat chronic pain and assist patients in tapering off opioids. This research follows the context of a significant public health issue, as approximately 5 million adults in the United States regularly use prescription opioids for chronic pain management.
Advertisement
The researchers emphasized that the study was the first to specifically examine the relationship between long-term opioid consumption and brain properties. While the study did not show that opioids improved pain, it also did not demonstrate that the long-term users were significantly worse off than the non-users in terms of overall neurological health. The findings serve as a foundation for future testing of drugs that target the specific molecular pathways identified during this investigation.
Source: Medical Xpress.
Prepared with AI assistance from the cited sources.
The Cali Reporter newsletter
The stories worth your time.
California, the country, and what comes next. Join our free newsletter for reporting that keeps you informed.
More in Health & Medicine
- Brain Energy Mismatches in Schizophrenia
A new study explores the potential role of energy bottlenecks in brain cells in explaining fragmented experiences of time, space, and self in schizophrenia.
- Brazil Reports First Mpox Death in 2026
Brazil has recorded its first mpox-related death in 2026, but public health officials are not classifying the current surge in cases as an outbreak, according to the Fiocruz Institute.
- Personalized Therapies for IBD May Target Specific Harmful Gut Bacteria
A study led by Dr. Lukas Mager and Prof. Kathy McCoy has identified two gut bacteria that promote inflammation in inflammatory bowel disease, opening the door for personalized treatments.